Full Press Release Details
Hyderabad, March 10, 2026 (GLOBE NEWSWIRE) -- The global molecular diagnostics market is witnessing significant expansion as healthcare systems increasingly adopt advanced diagnostic technologies to detect diseases at the genetic and molecular level. According to Mordor Intelligence, the molecular diagnostics market size is estimated to reach USD 20.41 billion in 2026 and is projected to expand to USD 33.51 billion by 2031, registering a CAGR of 10.43% during the forecast period, driven by increasing prevalence of infectious and chronic diseases, and rapid advancements in genomic and molecular testing technologies.
Molecular diagnostics plays a critical role in modern healthcare by enabling accurate detection of pathogens, genetic mutations, and biomarkers associated with various diseases. These tests support early diagnosis and personalized treatment planning, particularly in areas such as oncology, infectious diseases, genetic disorders, and prenatal testing. The growing focus on precision medicine and targeted therapies is further strengthening the adoption of molecular diagnostic tools across hospitals, laboratories, and research institutions worldwide. Technological innovation remains a key factor supporting market growth. Advancements in automated diagnostic platforms, rapid molecular testing kits, and portable diagnostic devices are improving laboratory efficiency and expanding testing capabilities. The integration of digital health platforms and advanced data analytics is also enhancing diagnostic accuracy and enabling more efficient disease monitoring.
Molecular Diagnostics Market Share by Region
North America holds a significant share of the molecular diagnostics market due to advanced healthcare infrastructure, strong research funding, and high adoption of innovative diagnostic technologies.
Europe represents another key market, supported by expanding research initiatives, growing emphasis on early disease detection, and the increasing use of molecular testing in clinical diagnostics.
Asia-Pacific is expected to witness notable growth during the forecast period, driven by expanding healthcare infrastructure, rising investments in biotechnology, and increasing awareness of advanced diagnostic technologies.
Other regions including the Middle East, Africa, and South America are also gradually adopting molecular diagnostic technologies as healthcare systems strengthen disease surveillance and diagnostic capabilities.
Molecular Diagnostics Market Trends & Forecast
Growing Demand for Early Disease Detection
Healthcare providers are increasingly utilizing molecular diagnostic tools to detect diseases at earlier stages, improving treatment outcomes and supporting preventive healthcare strategies.
Advancements in Genomic and Molecular Testing Technologies
Innovations in PCR technologies, sequencing platforms, and automated diagnostic systems are improving testing speed, accuracy, and scalability.
“Molecular diagnostics adoption is expanding as healthcare providers prioritize earlier detection and more informed treatment decisions. Mordor Intelligence uses transparent research frameworks and multi-source validation, giving executives a dependable basis for comparing market outlooks.” Says, Soumya Goud, Senior Research Manager, Mordor Intelligence
Molecular Diagnostics Market Segmentation Overview
Next-Generation Sequencing (NGS)
In Situ Hybridization
Genetic Disease Screening
Human Leukocyte Antigen Typing
Instruments & Systems
Blood, Serum & Plasma
Other Sample Types (Saliva, Tissue, Swabs)
Diagnostic & Reference Laboratories
Academic & Research Institutes
Rest of Asia-Pacific
Middle East and Africa
Rest of Middle East and Africa
Rest of South America
For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/molecular-diagnostics-market?utm_source=globenewswire
Molecular Diagnostics Market Competitive Outlook
The molecular diagnostics market features a combination of global diagnostic companies and biotechnology firms focusing on product innovation, research collaborations, and expansion of advanced diagnostic platforms. Companies are investing in automated testing systems, rapid molecular diagnostic kits, and next-generation sequencing technologies to strengthen their market presence and support the growing demand for precision diagnostics.
Molecular Diagnostics Companies include:
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories
Siemens Healthineers
Agilent Technologies Inc.
Check out related reports published by Mordor Intelligence
Next-Generation Cancer Diagnostics Market Size - The next-generation cancer diagnostics market stood at USD 15.34 billion in 2024 and is projected to reach USD 34.87 billion by 2030, growing at a CAGR of 9.6%. Market growth is driven by increasing cancer prevalence, rising adoption of genomic and molecular testing technologies, and expanding use of precision medicine approaches in oncology diagnostics.
Cervical Dysplasia Market Share - The cervical dysplasia market is estimated at USD 0.82 billion in 2026 and is projected to reach USD 1.14 billion by 2031, registering a CAGR of 6.78% during the forecast period. Growth is supported by increasing screening programs, rising awareness of cervical cancer prevention, and expanding adoption of diagnostic and treatment procedures for precancerous cervical conditions.
Point-of-Care Molecular Diagnostics Market Trends - The point-of-care molecular diagnostics market is estimated to grow from USD 4.65 billion in 2026 to USD 7.97 billion by 2031, registering a CAGR of 11.37% during the forecast period. Market expansion is driven by increasing demand for rapid diagnostic testing, growing prevalence of infectious diseases, and rising adoption of decentralized testing solutions in clinical settings.
F. Hoffmann-La Roche Ltd, Danaher Corporation, Thermo Fisher Scientific Inc., BioMérieux SA and Abbott Laboratories are the major companies operating in this market.
Read more about companies in the point-of-care molecular diagnostics market: https://www.mordorintelligence.com/industry-reports/point-of-care-molecular-diagnostics-market/companies?utm_source=globenewswire
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategicgoals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
Tags
Molecular Diagnostics Market
Molecular Diagnostics